1. 7 Outcomes of medically-treated patients with M2-segment middle cerebral artery occlusion. Results from the prospective multicentral international cohort study INTERRSeCT. (July 2018) Authors: Menon, B; Najm, M; Al-Ajlan, F; Almekhlafi, M; Puig, J; Castellanos, M; Dowlatshahi, D; Calleja, A; Sohn, S; Ahn, S; Poppe, A; Mikulik, R; Asdaghi, N; Field, T; Jin, A; Asil, T; Boulanger, J; Smith, E; Coutts, S; Barber, P Journal: Journal of neurointerventional surgery Issue: Volume 10(2018)Supplement 2 Page Start: A140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Issue 12 (December 2018) Authors: Kasner, Scott E; Swaminathan, Balakumar; Lavados, Pablo; Sharma, Mukul; Muir, Keith; Veltkamp, Roland; Ameriso, Sebastian F; Endres, Matthias; Lutsep, Helmi; Messé, Steven R; Spence, J David; Nedeltechev, Krassen; Perera, Kanjana; Santo, Gustavo; Olavarria, Veronica; Lindgren, Arne; Bangdiwala, S... Journal: Lancet neurology Issue: Volume 17:Issue 12(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗